Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone

The Veterans Administration Cooperative Study on Alcoholic Hepatitis

Research output: Contribution to journalArticle

211 Citations (Scopus)

Abstract

A cooperative study was conducted to determine the efficacy of 30 days of treatment with either a glucocorticosteroid (prednisolone) or an anabolic steroid (oxandrolone) in moderate or severe alcoholic hepatitis. One hundred thirty-two patients with moderate disease and 131 with severe disease were randomly assigned to one of three treatments: prednisolone, oxandrolone, or placebo. During the 30 days, mortality in the groups receiving steroid therapy was not significantly different from mortality in the placebo group. Thirteen percent of the moderately ill patients and 29 percent of the severely ill patients died. Although neither steroid improved short-term survival, oxandrolone therapy was associated with a beneficial effect on long-term survival. This was especially true in patients with moderate disease: among those who survived for one or two months after the start of treatment the conditional six-month death rate was 3.5 percent after oxandrolone and 19 to 20 percent after placebo (P = 0.02). No consistent long-term effect was associated with prednisolone therapy. (N Engl J Med 1984; 311:1464–70.).

Original languageEnglish (US)
Pages (from-to)1464-1470
Number of pages7
JournalNew England Journal of Medicine
Volume311
Issue number23
DOIs
StatePublished - Dec 6 1984

Fingerprint

Oxandrolone
Alcoholic Hepatitis
Prednisolone
Survival
Placebos
Mortality
Therapeutics
Testosterone Congeners
Steroids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone. / The Veterans Administration Cooperative Study on Alcoholic Hepatitis.

In: New England Journal of Medicine, Vol. 311, No. 23, 06.12.1984, p. 1464-1470.

Research output: Contribution to journalArticle

The Veterans Administration Cooperative Study on Alcoholic Hepatitis. / Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone. In: New England Journal of Medicine. 1984 ; Vol. 311, No. 23. pp. 1464-1470.
@article{3c4899eda4454905baef242868307050,
title = "Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone",
abstract = "A cooperative study was conducted to determine the efficacy of 30 days of treatment with either a glucocorticosteroid (prednisolone) or an anabolic steroid (oxandrolone) in moderate or severe alcoholic hepatitis. One hundred thirty-two patients with moderate disease and 131 with severe disease were randomly assigned to one of three treatments: prednisolone, oxandrolone, or placebo. During the 30 days, mortality in the groups receiving steroid therapy was not significantly different from mortality in the placebo group. Thirteen percent of the moderately ill patients and 29 percent of the severely ill patients died. Although neither steroid improved short-term survival, oxandrolone therapy was associated with a beneficial effect on long-term survival. This was especially true in patients with moderate disease: among those who survived for one or two months after the start of treatment the conditional six-month death rate was 3.5 percent after oxandrolone and 19 to 20 percent after placebo (P = 0.02). No consistent long-term effect was associated with prednisolone therapy. (N Engl J Med 1984; 311:1464–70.).",
author = "{The Veterans Administration Cooperative Study on Alcoholic Hepatitis} and Mendenhall, {Charles L.} and Sharon Anderson and Pedro Garcia-Pont and Stephen Goldberg and Thomas Kiernan and Kiernan, {Thomas W} and Michael Sorrell and Carlo Tamburro and Robert Weesner and Rowen Zetterman and Antonio Chedid and Thomas Chen and Lionel Rabin",
year = "1984",
month = "12",
day = "6",
doi = "10.1056/NEJM198412063112302",
language = "English (US)",
volume = "311",
pages = "1464--1470",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "23",

}

TY - JOUR

T1 - Short-Term and Long-Term Survival in Patients with Alcoholic Hepatitis Treated with Oxandrolone and Prednisolone

AU - The Veterans Administration Cooperative Study on Alcoholic Hepatitis

AU - Mendenhall, Charles L.

AU - Anderson, Sharon

AU - Garcia-Pont, Pedro

AU - Goldberg, Stephen

AU - Kiernan, Thomas

AU - Kiernan, Thomas W

AU - Sorrell, Michael

AU - Tamburro, Carlo

AU - Weesner, Robert

AU - Zetterman, Rowen

AU - Chedid, Antonio

AU - Chen, Thomas

AU - Rabin, Lionel

PY - 1984/12/6

Y1 - 1984/12/6

N2 - A cooperative study was conducted to determine the efficacy of 30 days of treatment with either a glucocorticosteroid (prednisolone) or an anabolic steroid (oxandrolone) in moderate or severe alcoholic hepatitis. One hundred thirty-two patients with moderate disease and 131 with severe disease were randomly assigned to one of three treatments: prednisolone, oxandrolone, or placebo. During the 30 days, mortality in the groups receiving steroid therapy was not significantly different from mortality in the placebo group. Thirteen percent of the moderately ill patients and 29 percent of the severely ill patients died. Although neither steroid improved short-term survival, oxandrolone therapy was associated with a beneficial effect on long-term survival. This was especially true in patients with moderate disease: among those who survived for one or two months after the start of treatment the conditional six-month death rate was 3.5 percent after oxandrolone and 19 to 20 percent after placebo (P = 0.02). No consistent long-term effect was associated with prednisolone therapy. (N Engl J Med 1984; 311:1464–70.).

AB - A cooperative study was conducted to determine the efficacy of 30 days of treatment with either a glucocorticosteroid (prednisolone) or an anabolic steroid (oxandrolone) in moderate or severe alcoholic hepatitis. One hundred thirty-two patients with moderate disease and 131 with severe disease were randomly assigned to one of three treatments: prednisolone, oxandrolone, or placebo. During the 30 days, mortality in the groups receiving steroid therapy was not significantly different from mortality in the placebo group. Thirteen percent of the moderately ill patients and 29 percent of the severely ill patients died. Although neither steroid improved short-term survival, oxandrolone therapy was associated with a beneficial effect on long-term survival. This was especially true in patients with moderate disease: among those who survived for one or two months after the start of treatment the conditional six-month death rate was 3.5 percent after oxandrolone and 19 to 20 percent after placebo (P = 0.02). No consistent long-term effect was associated with prednisolone therapy. (N Engl J Med 1984; 311:1464–70.).

UR - http://www.scopus.com/inward/record.url?scp=0021749036&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021749036&partnerID=8YFLogxK

U2 - 10.1056/NEJM198412063112302

DO - 10.1056/NEJM198412063112302

M3 - Article

C2 - 6390194

AN - SCOPUS:0021749036

VL - 311

SP - 1464

EP - 1470

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 23

ER -